GL1X · GenesisL1 explorer

Research workbench

Human HSP90 alpha N-terminal domain in complex with an aminotriazoloquinazoline inhibitor

Analyse Human HSP90 alpha N-terminal domain in complex with an aminotriazoloquinazoline… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4CWR
Type
protein
Length
207 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Heat shock protein HSP 90-alpha
UniProt
P07900
Ligands
HAJ
Pockets
1 · best druggability 0.68

Structure

x-ray diffraction · 1 distinct chain · 46% helix, 23% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AHeat shock protein HSP 90-alphaprotein20746% helix, 23% strandP07900

Ligands and binding sites

  • HAJ · 5-(1,3-benzodioxol-5-ylmethyl)-10-fluoro[1,2,4]triazolo[1,5-c]quinazolin-2-amine · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13010.680.8238HAJ

Compared structures

  • 4CWR · Human HSP90 alpha N-terminal domain in complex with an Aminotriazoloquinazoline inhibitor · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.